Evaluation of Skin Testing Reagents for Penicillin Allergy
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
A self- or parent-reported history of penicillin allergy excludes approximately 10% of the US
population from receiving penicillin (Kerr 1994, Kagy, Blaiss 1998, Solensky et al. 2000,
Neugut et al. 2001). Yet approximately 80% of patients labeled as allergic to the penicillins
can safely take these antibiotics without fear of a life-threatening reaction (Gadde et al.
1993, Macy et al. 1997). The outcomes of this erroneous classification of patients include
unnecessary denial of an effective and well-tolerated class of antibiotics, which are often
the treatment of choice.
The primary aim of skin testing with the Penicillin Skin Test Kit is to identify subjects at
very low risk of developing acute IgE-dependent reactions when given a penicillin or
cross-reacting drug. The negative predictive value (NPV) of skin testing is assessed by oral
challenge with a penicillin.